多囊卵巢综合征是妊娠期糖尿病和妊娠期高血压疾病的独立危险因素:基于910万次妊娠的人群研究
该回顾性人群研究利用美国HCUP-NIS数据库2004至2014年数据,纳入多囊卵巢综合征(PCOS)孕妇14 882例和非PCOS孕妇9 081 906例,控制混杂因素后PCOS孕妇妊娠期糖尿病、妊娠期高血压和子痫前期的风险均显著升高。
要点
- PCOS孕妇妊娠期糖尿病风险是非PCOS孕妇的2倍以上(aOR 2.19)。
- PCOS孕妇妊娠期高血压风险增加约50%(aOR 1.47)。
- PCOS孕妇子痫前期风险增加约30%(aOR 1.29)。
核心结论
- 控制所有潜在混杂因素后,PCOS孕妇发生妊娠期糖尿病的风险是非PCOS孕妇的2倍,妊娠期高血压风险增加50%,子痫前期风险增加30%。
研究设计与样本
- 回顾性人群研究,利用美国HCUP-NIS数据库2004至2014年共11年数据。
- 研究组为PCOS孕妇14 882例,对照组为非PCOS孕妇9 081 906例。
主要发现
- PCOS组与非PCOS组基线比较:肥胖22.3% vs 3.5%,慢性高血压8.4% vs 1.8%,孕前糖尿病4.1% vs 0.9%,甲状腺疾病治疗12.6% vs 2.4%,IVF治疗2.4% vs 0.1%,多胎妊娠5.9% vs 1.5%,多胎妊娠中IVF结果12.3% vs 2.3%,均P < 0.001。
- 控制混杂因素后,PCOS组妊娠期糖尿病aOR 2.19(95% CI 2.02-2.37),妊娠相关高血压aOR 1.38(95% CI 1.27-1.50,P < 0.001),妊娠期高血压aOR 1.47(95% CI 1.31-1.64),子痫前期aOR 1.29(95% CI 1.14-1.45),叠加子痫前期aOR 1.29(95% CI 1.04-1.59)。
- 所有妊娠与单胎妊娠中比值比相当;多胎妊娠中PCOS仅显著增加妊娠期糖尿病风险(aOR 2.33,95% CI 1.92-2.83,P < 0.001),妊娠相关高血压风险有升高趋势(aOR 1.92,95% CI 0.99-1.42,P = 0.058)。
临床怎么用
- 作者指出,即使没有其他共存代谢疾病,PCOS孕妇不良妊娠并发症风险仍增加。
- 作者指出,还需考虑PCOS妇女常合并的其他代谢疾病,这些风险叠加使PCOS孕妇不良妊娠并发症风险显著增加。
局限性
- 本研究为利用行政数据库的回顾性分析,依赖编码人员的准确性和一致性。
- 医院编码在捕获围产期状况和并发症方面的准确性存在已知局限性,难以确定这些事件是否准确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does polycystic ovary syndrome (PCOS) confer an independent risk for the development of gestational diabetes mellitus (GDM), gestational hypertension (GHTN) and preeclampsia (PEC) based on analysis of the Healthcare Cost and Utilization Project Nationwide Inpatient Sample (HCUP-NIS) database. SUMMARY ANSWER: After controlling for all potential confounding effects, women with PCOS are at a 2-fold higher risk of developing GDM, a 50% increased risk for the development of GHTN and a 30% increased risk of developing PEC than women without PCOS. WHAT IS KNOWN ALREADY: Currently, there is evidence of an increased prevalence of maternal pregnancy complications in women with PCOS. However, there remain significant gaps in understanding how PCOS affects the development of GDM, GHTN and PEC. This is most likely due to the complex, multifactorial etiology of PCOS, its range of potential confounders for pregnancy complications and the variable methodology of studies that have been conducted. To date, the largest meta-analysis on this subject includes 11 565 women with PCOS analyzed for their risk of GDM and 5896 patients analyzed for their risk of PEC. STUDY DESIGN, SIZE, DURATION: This is a retrospective population-based study utilizing data from the HCUP-NIS over 11 years from 2004 to 2014. A dataset of all deliveries between 2004 and 2014 inclusively was created. Within this group, all deliveries to women with PCOS were identified as part of the study group (n = 14 882), and the remaining deliveries were categorized as non-PCOS births and comprised the reference group (n = 9 081 906). PARTICIPANTS/MATERIALS, SETTING, METHODS: The HCUP-NIS is the largest inpatient sample database in the USA and is comprised of hospital inpatient stays submitted by hospitals throughout the entire country. Each year, the database provides information relating to 7 million inpatient stays, including patient characteristics, diagnosis and procedures. The data are representative of ∼20% of admissions to US hospitals across 48 states and the District of Columbia. MAIN RESULTS AND THE ROLE OF CHANCE: At baseline, more pregnant women with PCOS were obese (22.3% vs. 3.5%, P < 0.001), had chronic hypertension (HTN) (8.4% vs. 1.8%, P < 0.001), had pregestational diabetes (4.1% vs. 0.9%, P < 0.001) and had treated thyroid disease (12.6% vs. 2.4%, P < 0.001). Women with PCOS were also more likely to have undergone IVF treatment (2.4% vs. 0.1%, P < 0.001), have multi-gestation pregnancies (5.9% vs. 1.5%, P < 0.001), and more multiple gestations (MGs) in the PCOS group were the result of IVF treatment than the non-PCOS groups (12.3% vs. 2.3%, P < 0.001). In all pregnancies, women with PCOS were more likely to develop gestational diabetes (adjusted odds ratio (aOR) 2.19, 95% CI 2.02-2.37), pregnancy associated HTN (aOR 1.38, 95% CI 1.27-1.50, P < 0.001), GHTN (aOR 1.47, 95% CI 1.31-1.64), PEC (aOR 1.29, 95% CI 1.14-1.45) and superimposed PEC (aOR 1.29, 95% CI 1.04-1.59) after controlling for confounding effects (age, race, income level, insurance type, obesity, IVF use, previous cesarean section, chronic HTN, pregestational diabetes, thyroid disease, MG, smoking and recreational drug use). Odds ratios were comparable between all pregnancies and singleton pregnancies only. In women pregnant with multiple fetuses, PCOS only conferred a statistically significant increased risk of developing GDM (aOR 2.33, 95% CI 1.92-2.83, P < 0.001). However, there was a trend toward an increased risk for developing pregnancy associated HTN (aOR 1.92, 95% CI 0.99-1.42, P = 0.058). LIMITATIONS, REASONS FOR CAUTION: This is a retrospective analysis utilizing an administrative database which relies on the accuracy and consistency of the individuals coding the data. There are known limitations in how accurately hospital coding is able to capture perinatal conditions and complications, making it difficult to know with certainty that such events are accurate. WIDER IMPLICATIONS OF THE FINDINGS: Pregnant women with PCOS are at increased risk of adverse complications in pregnancy even when they do not present with other coexisting metabolic conditions. Furthermore, it is important to also consider the risk of all other coexisting metabolic conditions frequently encountered in PCOS women, as these risks are additive and place women with PCOS at significantly increased risk for adverse complications in pregnancy. STUDY FUNDING/COMPETING INTEREST(S): None.
引用
- Mills G, Badeghiesh A, Suarthana E, et al. Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies. Hum Reprod. 2020. PMID: 32535629. doi:10.1093/humrep/deaa099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。